EGFR and ischemia: To identify the role for EGFR transactivation, the AG1478, an inhibitor of EGFR or GM6001, an inhibitor of Zn2+-dependent metalloproteinase and therefore the subsequent shedding of growth factor(s) were injected intraventricularly before ischemia.